Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “First Line Platinum Chemotherapy”

255 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 255 results

Large-scale testing (Phase 3)Study completedNCT02184195
What this trial is testing

Olaparib in gBRCA Mutated Pancreatic Cancer Whose Disease Has Not Progressed on First Line Platinum-Based Chemotherapy

Who this might be right for
Germline BRCA1/2 Mutations andMetastatic Adenocarcinoma of the Pancreas
AstraZeneca 154
Large-scale testing (Phase 3)UnknownNCT04203485
What this trial is testing

Camrelizumab Combined With Apatinib Mesylate or Camrelizumab Alone for First-line Treatment in Subjects With Programmed Death Ligand 1 (PD-L1) Positive Relapsed or Advanced Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
PD-L1 Positive Non-small Cell Lung Cancer
Jiangsu HengRui Medicine Co., Ltd. 762
Large-scale testing (Phase 3)Active Not RecruitingNCT04765059
What this trial is testing

Evaluate Chemotherapy Plus Osimertinib Against Chemotherapy Plus Placebo in Patients With Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer
AstraZeneca 98
Not applicableEnded earlyNCT01142869
What this trial is testing

An Observational Study to Evaluate the Safety and Efficacy of Cetuximab in Combination With Platinum-based Chemotherapy in the First-line Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck

Who this might be right for
Carcinoma, Squamous Cell
Merck KGaA, Darmstadt, Germany 133
Not applicableActive Not RecruitingNCT06269133
What this trial is testing

Evaluation of Cemiplimab in Combination With Platinum-Doublet Chemotherapy in First-Line (1L) Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) in Adult United States (US) Patients

Who this might be right for
Advanced Non-small Cell Lung Cancer
Regeneron Pharmaceuticals 1,000
Large-scale testing (Phase 3)Active Not RecruitingNCT02542293
What this trial is testing

Study of Durvalumab With Tremelimumab Versus SoC as 1st Line Therapy in Metastatic Non Small-Cell Lung Cancer (NSCLC) (NEPTUNE)

Who this might be right for
Non Small Cell Lung Carcinoma NSCLC
AstraZeneca 953
Large-scale testing (Phase 3)Looking for participantsNCT06954584
What this trial is testing

Fluzoparib+Bevacizumab/Dietary Intervention vs Fluzoparib Monotherapy as First-line Maintenance in HRD+/- Advanced Ovarian Cancer

Who this might be right for
Ovarian Cancer
Tongji Hospital 424
Not applicableStudy completedNCT03170284
What this trial is testing

Observational Study to Evalute the Efficacy and Safety of Avastin (Bevacizumab) in Addition to Platinum-Based Chemotherapy for First-Line Treatment of Participants With Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Hoffmann-La Roche 150
Testing effectiveness (Phase 2)Looking for participantsNCT06663098
What this trial is testing

Atezolizumab and Rechallenge Chemotherapy in Relapsed Patients With Extensive-stage Small Cell Lung Cancer (ES-SCLC).

Who this might be right for
Extensive Stage Small Cell Lung Cancer (ES-SCLC)
Gruppo Oncologico Italiano di Ricerca Clinica 142
Large-scale testing (Phase 3)Study completedNCT02538666
What this trial is testing

An Investigational Immuno-therapy Study of Nivolumab, or Nivolumab in Combination With Ipilimumab, or Placebo in Patients With Extensive-Stage Disease Small Cell Lung Cancer (ED-SCLC) After Completion of Platinum-based Chemotherapy

Who this might be right for
Lung Cancer
Bristol-Myers Squibb 907
Testing effectiveness (Phase 2)WithdrawnNCT05998941
What this trial is testing

A Trial of TQB2868 Plus Platinum-based Chemotherapy With or Without Bevacizumab in the First-line Treatment of Persistent, Recurrent, or Metastatic Cervical Cancer

Who this might be right for
Cervical Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Early research (Phase 1)Study completedNCT00879866
What this trial is testing

EMD 521873 Plus Radiotherapy in Non Small Cell Lung Cancer (NSCLC)

Who this might be right for
Lung CancerNon Small Cell Lung Cancer
Merck KGaA, Darmstadt, Germany 15
Testing effectiveness (Phase 2)Study completedNCT00489983
What this trial is testing

Trial of Pemetrexed or Pemetrexed With Gemcitabine for Patients With Advanced Lung Cancer Who Are Not Eligible for Platinum-Based Chemotherapy and Have Not Previously Been Treated With Chemotherapy

Who this might be right for
Non-Small Cell Lung Cancer
Eli Lilly and Company 91
Testing effectiveness (Phase 2)Looking for participantsNCT06403111
What this trial is testing

FMT+Immunotherapy+Chemotherapy As First-line Treatment for Driver-gene Negative Advanced NSCLC

Who this might be right for
Non-small Cell Lung Cancer
Changzhou No.2 People's Hospital 62
Testing effectiveness (Phase 2)Study completedNCT00828841
What this trial is testing

Phase 2b Study of Cetuximab With Platinum-Based Chemo as First Line Treatment of Recurrent or Advanced NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
Accelerated Community Oncology Research Network 601
Testing effectiveness (Phase 2)Ended earlyNCT00404703
What this trial is testing

Avastin (Bevacizumab) in Combination With Platinum-Based Chemotherapy in Patients With Advanced or Recurrent Squamous Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Hoffmann-La Roche 37
Large-scale testing (Phase 3)Active Not RecruitingNCT03522246
What this trial is testing

A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy

Who this might be right for
Epithelial Ovarian CancerPrimary PeritonealFallopian Tube Cancer+4 more
pharmaand GmbH 1,097
Testing effectiveness (Phase 2)Ended earlyNCT00791154
What this trial is testing

QUILT-2.013: First-Line Treatment for Extensive Stage Small Cell Lung Cancer

Who this might be right for
Lung CancerSmall Cell Lung CancerSolid Tumors+1 more
NantCell, Inc. 213
Large-scale testing (Phase 3)Study completedNCT01652469
What this trial is testing

Testing of Drugs Erlotinib and Docetaxel in Lung Cancer Patients Classified Regarding Their Outlook Using VeriStrat®.

Who this might be right for
Carcinoma, Non-Small-Cell Lung
ETOP IBCSG Partners Foundation 81
Large-scale testing (Phase 3)Active Not RecruitingNCT04982237
What this trial is testing

AK104 Plus Platinum-containing Chemotherapy±Bevacizumab as First-line Treatment for Persistent, Recurrent, or Metastatic Cervical Cancer

Who this might be right for
Cervical Cancer
Akeso 445
Load More Results